📰 **Santhera Receives Positive CHMP Opinion In Age Range Expansion For AGAMREE In Treating DMD **

(RTTNews) - Santhera Pharmaceuticals Holdings AG (SANN.SW), a specialty pharmaceutical company, announced on Monday receipt of a positive opinion from the committee for medicinal products for human use (CHMP), authorizing the age expansion for AGAMREE in treating Duchenne's muscu...

🔗 https://www.nasdaq.com/articles/santhera-receives-positive-chmp-opinion-age-range-expansion-agamree-treating-dmd

#markets #news